CIK 0000744218
- Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133191702
- Phone
- +1 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-08 | van den Broek Richard Director | Grant or award | +10,000 | 233,500 | ||
| 2016-06-08 | van den Broek Richard Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-08 | Elston George Director | Grant or award | +10,000 | 28,500 | ||
| 2016-06-08 | Elston George Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-08 | LIPTON KAREN SHOOS Director | Grant or award | +10,000 | 31,833 | ||
| 2016-06-08 | LIPTON KAREN SHOOS Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-08 | CONRAD HERBERT J Director | Grant or award | +10,000 | 28,500 | ||
| 2016-06-08 | CONRAD HERBERT J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-08 | PENNER HARRY JR Director | Grant or award | +10,000 | 31,916 | ||
| 2016-06-08 | PENNER HARRY JR Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-08 | ELLBERGER LARRY Director | Grant or award | +10,000 | 63,500 | ||
| 2016-06-08 | ELLBERGER LARRY Director | Grant or award · Non-Qualified Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2016-06-03 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +20,000 | $2.80 | $56K | 70,739 |
| 2016-06-03 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +2,847 | $4.50 | $13K | 73,586 |
| 2016-06-03 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Option | −20,000 | 0 | ||
| 2016-06-03 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Option | −2,847 | 5,000 | ||
| 2016-03-09 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +15,000 | $2.80 | $42K | 50,739 |
| 2016-03-09 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Option | −15,000 | 20,000 | ||
| 2015-11-23 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +25,000 | $8.52 | $213K | 60,109 |
| 2015-11-23 | CATLIN AVERY W Sr. VP & CFO | Sale | −25,000 | $18.00 | $450K | 35,109 |
Page 20 of 32 · 629 trades